AzTrials
AzTrials

StrokeMUKU2NCT01749709

Effect of Daily Music Listening on Stroke Recovery

A study testing Music listening and Audiobook listening in people with Stroke, run by Turku University Hospital at 1 site in Finland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Single blind randomized clinical trial including 50 stroke patients to investigate the effect of daily music listening on behavioral, neural and physiological recovery. Patients are randomized (1:1:1) to listen instrumental or vocal music, or audiobooks (recorded book reading) (control). Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Stroke
What is being tested?
Music listening and Audiobook listening
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteFinland
Study dates
Dec 2012to 5 Apr 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Acute Hemispheral stroke

Who cannot join

  • Previous neurological or current psychiatric disease,
  • severe aphasia

Trial locations and contacts

1 site in 1 country.

Finland1 site
  • Turku University Hospital

    Turku

Other trials in Finland

About this study

Official title: Effect of Cognitive Stimulation on Recovery After Stroke

Single blind randomized clinical trial including 50 stroke patients to investigate the effect of daily music listening on behavioral, neural and physiological recovery. Patients are randomized (1:1:1) to listen instrumental or vocal music, or audiobooks (recorded book reading) (control). Outcome measures are change in neuropsychological tests, change in self-reported mood, structural and functional magnetic resonance imaging changes and hormonal changes performed at acute, 3-month and 6-month stages.

Read the detailed description

Please see above

Conditions
Stroke
Being tested
Music listening, Audiobook listening
Keywords
Stroke, Recovery, Music
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Music listeningBehavioural

  • Audiobook listeningBehavioural

Study groups in NCT01749709
Study groupRoleWhat they receive
Instrumental music listeningExperimentalDaily music listening
Receives: Behavioral: Music listening
Vocal music listeningExperimentalDaily music listening
Receives: Behavioral: Music listening
Audiobook listening (control)Active comparatorDaily audiobook listening
Receives: Behavioral: Audiobook listening

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in neuropsychological performance (verbal memory)

    Verbal memory summary score (Rivermead Behavioral Memory Test (RBMT) story recall, auditory-verbal learning task)

    Measured: From acute to 3-month-stage

  2. Change in neuropsychological performance (verbal memory)

    Verbal memory summary score (RBMT story recall, auditory-verbal learning task)

    Measured: From acute to 6-month-stage

Secondary outcomes (20)
  1. Change in neuropsychological performance (Language skill)

    Verbal fluency task

    Measured: From acute to 3-month-stage

  2. Change in neuropsychological performance (Language skill)

    Naming test CERAD/Boston Naming Test (BNT)

    Measured: From acute to 3-month-stage

  3. Change in neuropsychological performance (Language skill)

    Short Token Test

    Measured: From acute to 3-month-stage

  4. Change in neuropsychological performance (Language skill)

    Verbal fluency task

    Measured: From acute to 6-month-stages

  5. Change in neuropsychological performance (Language skill)

    Naming test CERAD/BNT

    Measured: From acute to 6-month-stages

  6. Change in neuropsychological performance (Language skill)

    Short Token Test

    Measured: From acute to 6-month-stages

  7. Change in mood

    Profile of Mood States

    Measured: From acute to 3-month-stage

  8. Change in mood

    Profile of Mood States

    Measured: From acute to 6-month-stage

  9. Change in structural gray matter

    Voxel-based morphometry

    Measured: From acute to 3-month-stage

  10. Change in structural gray matter changes

    Voxel-based morphometry

    Measured: From acute to 6-month-stage

  11. Change in structural white matter

    Diffusion-weighted imaging

    Measured: From acute to 3-month stage

  12. Change in structural white matter

    Diffusion-weighted imaging

    Measured: From acute to 6-month stage

  13. Change in neuronal function

    Resting state/task-based fMRI

    Measured: From acute to 3-month stage

  14. Change in neuronal function

    Resting state/task-based fMRI

    Measured: From acute to 6-month stage

  15. Change in physiological stress level

    Cortisol serum concentration

    Measured: From acute to 3-month-stage

  16. Change in physiological stress level

    Cortisol serum concentration

    Measured: From acute to 6-month-stage

  17. Change in physiological stress level

    Beta-endorphin serum concentration

    Measured: From acute to 3-month-stage

  18. Change in physiological stress level

    Beta-endorphin serum concentration

    Measured: From acute to 6-month-stage

  19. Change in physiological stress level

    Oxytocin serum concentration

    Measured: From acute to 3-month-stage

  20. Change in physiological stress level

    Oxytocin serum concentration

    Measured: From acute to 6-month-stage

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Dec 2012 (estimated)
  2. Study startDec 2012
  3. Primary completion5 Apr 2016
  4. Study completion5 Apr 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01749709
Sponsor's protocol ID
85/180/2011
Acronym
MUKU2
Status last verified
Dec 2021
First submitted
12 Dec 2012
Last updated
5 Jan 2022
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Music listening and Audiobook listening in people with Stroke, run by Turku University Hospital at 1 site in Finland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in neuropsychological performance (verbal memory) (time frame: From acute to 3-month-stage). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jan 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in